Kedudukan dalam Saham
#39749
Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a... Established in 2008 and based in York, United Kingdom, Abingdon Health Plc is a global entity dedicated to the creation, production, and worldwide distribution of diagnostic instruments. Their product line features the AbC-19 Rapid Test, a fast-acting diagnostic for COVID-19 IgG antibodies, alongside various nucleic acid lateral flow immunoassays. They also offer Seralite, a swift lateral flow test for accurately measuring kappa and lambda immunoglobulin free light chains in blood serum. Additionally, their AppDx technology converts any smartphone into an autonomous and adaptable lateral-flow reader. Beyond these offerings, the company provides expert services in lateral flow development and manufacturing, as well as advisory support to firms in the health tech industry. Abingdon Health Plc also engages in a collaborative and co-marketing partnership with Abcam plc.
Harga Saham
$0.14287366
Disegerakkan terakhir: 2026-08-13
Perubahan (1 tahun)
68.97%
Perdagangan Abingdon Health Plc (ABDX)
Harga ABDX dengan permodalan pasaran b
Modal pasaran bagi Abingdon Health Plc(ABDX)
Modal Pasaran: $361.12K
Sehingga August 2026, Abingdon Health Plc mempunyai modal pasaran sebanyak $361.12K. Ini menjadikan Abingdon Health Plc syarikat ke-39749th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Abingdon Health Plc dari 2020 hingga 2026
ABDX berbanding dengan 5 teratas yang paling popular stocks
| Harga ABDX |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.470T
|
+1,514,620,443.86%
|
|
|
|
|
$4.467T
|
+1,237,018,107.01%
|
|
|
|
|
$4.174T
|
+1,155,968,028.42%
|
|
|
|
|
$3.700T
|
+1,024,622,698.91%
|
|
|
|
|
$2.854T
|
+790,422,467.20%
|
